Publications for Veronika Borutinskaité
Co-author map based on ISI articles 2007-
Journal Articles
Veronika Borutinskaité, Karl-Eric Magnusson and R Navakauskiene
alpha-Dystrobrevin distribution and association with other proteins in human promyelocytic NB4 cells treated for granulocytic differentiation
MOLECULAR BIOLOGY REPORTS, 2011, 38(5), 3001-3011.
Fulltext  Web of Science® Times Cited: 4 |
Mikhail Khotin, Lidia Turoverova, Vasilisa Aksenova, Nikolai Barlev, Veronika Borutinskaité, Alexander Vener, Olga Bajenova, Karl-Eric Magnusson, George P. Pinaev and Dmitri Tentler
Proteomic analysis of ACTN4-interacting proteins reveals its a putative involvement in mRNA metabolism
Biochemical and Biophysical Research Communications - BBRC, 2010, 397(2), 192-196.
Web of Science® Times Cited: 3 |
Jurate Savickiene, Grazina Treigyte, Veronika Borutinskaite, Ruta Navakauskiene and Karl-Eric Magnusson
The histone deacetylase inhibitor FK228 distinctly sensitizes the human leukemia cells to retinoic acid-induced differentiation
Annals of the New York Academy of Sciences, 2006, 1091, 368-384.
Web of Science® Times Cited: 13 |
Veronica Borutinskaite, Ruta Navakauskiene and Karl-Eric Magnusson
Retinoic acid and histone deacelytase inhibitor BML-210 inhibit proliferation of human cervical cancer HeLa cells
Annals of the New York Academy of Sciences, 2006, 1091, 346-355.
Web of Science® Times Cited: 12 |
Jurate Savickiene, Veronika-Viktorija Borutinskaite, Grazina Treigyte, Karl-Eric Magnusson and Ruta Navakauskiene
The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines
European Journal of Pharmacology, 2006, 549(1-3), 9-18.
Web of Science® Times Cited: 17 |
Veronica Borutinskaite, Karl-Eric Magnusson and Ruta Navakauskiene
Effects of retinoic acid and histone deacetylase inhibitor Bml-210 on protein expression in NB4 cells
Biologija, 2005, 4, 88-93.
|
Ph.D. Theses
Ph.D., Lic. Theses
